Evaluation of a multimarker panel in chronic heart failure: a 10-year follow-up

Biomark Med. 2021 Dec;15(18):1709-1719. doi: 10.2217/bmm-2020-0722. Epub 2021 Nov 16.

Abstract

Aim: We assessed the 10-year prognostic role of 11 biomarkers with different pathophysiological backgrounds. Materials & methods/results: Blood samples from 144 patients with heart failure were analyzed. After 10 years of follow-up (median follow-up was 104 months), data regarding all-cause mortality were acquired. Regarding Kaplan-Meier analysis, all markers, except TIMP-1 and GDF-15, were significant predictors for all-cause mortality. We created a multimarker model with nt-proBNP, hs-TnT and IGF-BP7 and found that patients in whom all three markers were elevated had a significantly worse long-time prognosis than patients without elevated markers. Conclusion: In a 10-year follow-up, a combination of three biomarkers (NT-proBNP, hs-TnT, IGF-BP7) identified patients with a high risk of mortality.

Keywords: IGF-BP7; NT-proBNP; heart failure; hs-TnT; multimarker panel; prognostication.

MeSH terms

  • Aged
  • Area Under Curve
  • Biomarkers / blood*
  • Chronic Disease
  • Female
  • Follow-Up Studies
  • Heart Failure / blood*
  • Heart Failure / mortality
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Models, Biological
  • Prognosis
  • Proportional Hazards Models

Substances

  • Biomarkers